An Open-Label Exploratory Phase 2/3 Study of Nivolumab with Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Metastatic Colorectal Cancer

Type of Cancer
Colon Oncology

Site
Bethesda

Protocol Number
CA209-9X8

To Learn More Call
(201)-510-0950